CannamedaiS.A.
Other research and experimental development on natural sciences and engineering
Overview
Cannamedai is a company that specializes in the research and development of cannabis-based therapies, utilizing advanced AI algorithms to analyze large datasets from cannabis research. It focuses on improving the health outcomes of oncology patients by personalizing cannabis treatments to meet individual patient needs. The company collaborates with scientists, doctors, and regulators to ensure its innovations are scientifically validated and compliant with regulations.
Financials
The financial statement for 2024 has not yet been filed with the Financial Document Repository (past deadline).
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2023.
Results vs industry
Industry
Bank accounts
Was a VAT taxpayer from 2022-02-15 to 2026-01-21. Removed from VAT register
Reason for removal: Art. 96 ust. 9a pkt 3 (VAT returns showing no transactions filed for 6 consecutive months or 2 quarters)
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
No public aid cases recorded in the last 10 years.
Tenders
No recorded participation in tenders.
Authorized Representatives
Manner of representation
The company is represented by: 1. in the case of a one-person management board – the sole member of the management board acting independently. 2. in the case of a management board consisting of more than one person – two members of the management board jointly, or one member of the management board jointly with a commercial proxy. 3. The management board may incur obligations on behalf of the company or dispose of a right with a value not exceeding PLN 500,000.00 (five hundred thousand zlotys). Above this amount, it must obtain the consent of the supervisory board.
Supervisory board
Beneficial owners
| Person | Rights | |
|---|---|---|
Wojciech Marcin Buczyński (48)  | Shareholder of a joint-stock company, 25.0% | |
Jerzy Wojciech Nowak (77) | Shareholder of a joint-stock company, 25.0% | |
Jarosław Damian Regent (46) | Shareholder of a joint-stock company, 25.0% | |
Barbara Ewa Wieteska (74) | Posiadane 91%udziałów w sp. zakupomania sp. zo.o., która posiada 25% akcji w spółce konopie.pl s.a. |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Digital Pathology Teamsp. z o.o. | $64,552.91 | digitalpathologyteam.com | ||
| New Valuesp. z o.o. | $64,335.86 | new-value.pl | ||
| Receptonsp. z o.o. | $50,611.05 | receptonbiotech.com | ||
| Biostat Research And Developmentsp. z o.o. | $50,225.77 | biostat.com.pl | ||
| Zawamedsp. z o.o. | $43,909.06 | zawamed.pl | ||
| Stenocoatsp. z o.o. | $36,665.21 | stenocoat.com | ||
| NanovelosS.A. | $24,842.03 | nanovelos.com | ||
| Medaisp. z o.o. | $22,311.83 | medai.pl | ||
| InventroS.A. | $12,176.61 | inventro.co | ||
| Detoxedsp. z o.o. | $11,972.37 | detoxed.pl |
Change history
| Date | Event | |
|---|---|---|
| 2024-06-11 | Address change (Ul. Bartosza Głowackiego 25-27/8a, 45-110, Opole → Ul. Bartosza Głowackiego 25-27/8c, 45-110, Opole) | |
| 2024-06-11 | Name change (Konopie.pl → Cannamedai) | |
| 2024-06-11 | PKD change (Removed: 10.41.Z, 10.86.Z, 32.99.Z, 46.21.Z, 47.11.Z, 47.75.Z, 70.22.Z; Added: 01.11.Z, 47.29.Z, 72.19.Z, 86.21.Z, 86.22.Z, 86.90.E, 96.04.Z) | |
| 2024-02-29 | Address change (Ul. Ozimska 38/2a, 45-058, Opole → Ul. Bartosza Głowackiego 25-27/8a, 45-110, Opole) | |
| 2022-05-16 | Address change (Ul. Sieradzka 17/36, 45-304, Opole → Ul. Ozimska 38/2a, 45-058, Opole) |
FAQ
Last updated: 2026-04-01